Apollo Hospitals Reports Strong Q1 FY2027 Results as Digital Unit Nears Breakeven
India's largest hospital chain delivered 21% consolidated revenue growth while its digital healthcare vertical cut losses by 80% year-over-year.
Broad-Based Growth Across All Divisions
Apollo Hospitals Enterprise Limited reported consolidated revenue of INR 7,043 crores for the first quarter of fiscal year 2027, representing 21% year-over-year growth, according to its earnings call. The healthcare conglomerate, with a market capitalization of approximately $13 billion, delivered double-digit growth across all three business verticals while expanding profitability (earnings call, 2026-08-13).
Consolidated EBITDA reached INR 1,092 crores, up 28% year-over-year, with margins improving to 15.5% from 14.6% in the prior-year period. Managing Director Suneeta Reddy attributed the performance to "sustained demand across our integrated health care platform, continued action and high acuity specialties and visiting execution across all 3 businesses" (earnings call, 2026-08-13).
Hospital Division Maintains Strong Momentum
The Healthcare Services division reported revenues of INR 3,567 crores, growing 22% year-over-year. Established hospitals contributed INR 3,475 crores, up 18%, while new hospitals added INR 92 crores. Growth was driven by 11% volume growth, 4% from pricing, and 3% from improvements in clinical case mix, bed mix, and payer mix (earnings call, 2026-08-13).
Total inpatient volumes increased 13% with occupancy at 70%. Average revenue per patient rose 8% to INR 186,630. The company's focus on high-acuity specialties—cardiac, oncology, transplant, neurosciences, gastroenterology, and orthopedics—showed results, with these areas growing 24% and now representing 62% of inpatient net revenues (earnings call, 2026-08-13).
Healthcare Services EBITDA grew 20% to INR 862 crores, with margins of 24.2%. Established hospitals delivered EBITDA margins of 25.9%, while new hospitals reported losses of INR 38 crores. Management expects new hospital losses to remain within the guided INR 150 crores annually, though quarterly losses may increase temporarily with the upcoming launch of the Gurugram facility, slated for Q3 operationalization (earnings call, 2026-08-13).
Digital Business Approaches Profitability
Apollo HealthCo, the company's integrated retail and digital healthcare business, reported revenues of INR 2,977 crores, up 20% year-over-year. More notably, digital cash losses narrowed to just INR 10 crores from INR 49 crores in the prior-year quarter. "The digital vertical is poised to achieve breakeven in the upcoming quarter," Reddy stated (earnings call, 2026-08-13).
Platform GMV stood at INR 535 crores, representing 23% growth. Apollo HealthCo reported PAT of INR 101 crores compared to INR 57 crores in the prior year.
Expansion Plans and Regulatory Outlook
The company continues expanding capacity, having operationalized a 180-bed facility in Sarjapur, Bangalore during the quarter. Management outlined expansion plans through FY 2031 that will increase census bed capacity to 14,100 beds, funded largely from internal cash flows (earnings call, 2026-08-13).
Reddy also addressed recent parliamentary committee recommendations on healthcare pricing, expressing support for the government's goals while cautioning that "one size fits all approach to pricing will not work as health care is more than merely a linear sum of imports." The company emphasized its role in reversing medical tourism trends, noting that patients from 150 countries now seek treatment in India (earnings call, 2026-08-13).
This article was generated by MarginX from the earnings call on 2026-08-13. It is not investment advice.